vs
Rhinebeck Bancorp, Inc.（RBKB）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
Rhinebeck Bancorp, Inc.的季度营收约是TriSalus Life Sciences, Inc.的1.0倍（$13.5M vs $13.2M），Rhinebeck Bancorp, Inc.净利率更高（17.3% vs -73.9%，领先91.2%），Rhinebeck Bancorp, Inc.同比增速更快（1701.1% vs 59.8%），Rhinebeck Bancorp, Inc.自由现金流更多（$10.9M vs $-2.5M），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs 14.0%）
Rhinebeck Bancorp, Inc.是总部位于美国纽约的区域性银行控股企业，旗下运营莱茵贝克银行，主要面向纽约哈德逊谷地区的个人消费者与中小企业提供储蓄、贷款、抵押贷款、财富管理等零售及商业金融服务。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
RBKB vs TLSI — 直观对比
营收规模更大
RBKB
是对方的1.0倍
$13.2M
营收增速更快
RBKB
高出1641.2%
59.8%
净利率更高
RBKB
高出91.2%
-73.9%
自由现金流更多
RBKB
多$13.4M
$-2.5M
两年增速更快
TLSI
近两年复合增速
14.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $13.2M |
| 净利润 | $2.3M | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | 21.7% | -24.8% |
| 净利率 | 17.3% | -73.9% |
| 营收同比 | 1701.1% | 59.8% |
| 净利润同比 | 188.0% | 3.5% |
| 每股收益（稀释后） | $0.21 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RBKBTLSI
| Q4 25 | $13.5M | $13.2M | ||
| Q3 25 | $14.0M | $11.6M | ||
| Q2 25 | $13.1M | $11.2M | ||
| Q1 25 | $12.8M | $9.2M | ||
| Q4 24 | $750.0K | $8.3M | ||
| Q3 24 | $773.0K | $7.3M | ||
| Q2 24 | $10.7M | $7.4M | ||
| Q1 24 | $10.4M | $6.5M |
净利润RBKBTLSI
| Q4 25 | $2.3M | $-9.8M | ||
| Q3 25 | $2.7M | $-10.8M | ||
| Q2 25 | $2.7M | $-8.3M | ||
| Q1 25 | $2.3M | $-10.4M | ||
| Q4 24 | $-2.7M | $-10.1M | ||
| Q3 24 | $-8.1M | $-2.4M | ||
| Q2 24 | $975.0K | $-4.3M | ||
| Q1 24 | $1.1M | $-13.2M |
毛利率RBKBTLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率RBKBTLSI
| Q4 25 | 21.7% | -24.8% | ||
| Q3 25 | 23.9% | -77.9% | ||
| Q2 25 | 26.6% | -65.4% | ||
| Q1 25 | 22.9% | -79.9% | ||
| Q4 24 | -444.9% | -91.8% | ||
| Q3 24 | -1332.3% | -118.9% | ||
| Q2 24 | 11.8% | -111.0% | ||
| Q1 24 | 13.9% | -180.8% |
净利率RBKBTLSI
| Q4 25 | 17.3% | -73.9% | ||
| Q3 25 | 19.3% | -93.5% | ||
| Q2 25 | 20.8% | -73.9% | ||
| Q1 25 | 17.9% | -113.2% | ||
| Q4 24 | -353.9% | -122.4% | ||
| Q3 24 | -1042.9% | -32.6% | ||
| Q2 24 | 9.2% | -58.8% | ||
| Q1 24 | 10.8% | -204.5% |
每股收益（稀释后）RBKBTLSI
| Q4 25 | $0.21 | $-0.22 | ||
| Q3 25 | $0.25 | $-0.96 | ||
| Q2 25 | $0.25 | $-0.27 | ||
| Q1 25 | $0.21 | $-0.39 | ||
| Q4 24 | $-0.24 | $-0.38 | ||
| Q3 24 | $-0.75 | $-0.12 | ||
| Q2 24 | $0.09 | $-0.21 | ||
| Q1 24 | $0.10 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $136.9M | $-33.9M |
| 总资产 | $1.3B | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RBKBTLSI
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
股东权益RBKBTLSI
| Q4 25 | $136.9M | $-33.9M | ||
| Q3 25 | $133.0M | $-26.7M | ||
| Q2 25 | $129.0M | $-19.4M | ||
| Q1 25 | $126.0M | $-34.4M | ||
| Q4 24 | $121.8M | $-25.9M | ||
| Q3 24 | $122.7M | $-20.4M | ||
| Q2 24 | $116.2M | $-25.3M | ||
| Q1 24 | $114.3M | $-36.0M |
总资产RBKBTLSI
| Q4 25 | $1.3B | $35.3M | ||
| Q3 25 | $1.3B | $36.5M | ||
| Q2 25 | $1.3B | $41.3M | ||
| Q1 25 | $1.3B | $28.6M | ||
| Q4 24 | $1.3B | $24.0M | ||
| Q3 24 | $1.3B | $27.5M | ||
| Q2 24 | $1.3B | $32.4M | ||
| Q1 24 | $1.3B | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.7M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $10.9M | $-2.5M |
| 自由现金流率自由现金流/营收 | 80.6% | -19.1% |
| 资本支出强度资本支出/营收 | 6.3% | 0.3% |
| 现金转化率经营现金流/净利润 | 5.03× | — |
| 过去12个月自由现金流最近4个季度 | $19.4M | $-19.1M |
8季度趋势，按日历期对齐
经营现金流RBKBTLSI
| Q4 25 | $11.7M | $-2.5M | ||
| Q3 25 | $2.2M | $-3.7M | ||
| Q2 25 | $2.4M | $-7.3M | ||
| Q1 25 | $4.3M | $-4.5M | ||
| Q4 24 | $8.5M | $-5.7M | ||
| Q3 24 | $-3.6M | $-10.8M | ||
| Q2 24 | $12.0M | $-13.4M | ||
| Q1 24 | $-3.5M | $-10.9M |
自由现金流RBKBTLSI
| Q4 25 | $10.9M | $-2.5M | ||
| Q3 25 | $2.0M | $-3.9M | ||
| Q2 25 | $2.2M | $-7.4M | ||
| Q1 25 | $4.2M | $-5.3M | ||
| Q4 24 | $7.7M | $-5.8M | ||
| Q3 24 | $-3.6M | $-11.0M | ||
| Q2 24 | $11.8M | $-13.5M | ||
| Q1 24 | $-3.7M | $-10.9M |
自由现金流率RBKBTLSI
| Q4 25 | 80.6% | -19.1% | ||
| Q3 25 | 14.5% | -33.9% | ||
| Q2 25 | 17.2% | -66.1% | ||
| Q1 25 | 32.8% | -57.3% | ||
| Q4 24 | 1023.9% | -69.7% | ||
| Q3 24 | -469.0% | -149.9% | ||
| Q2 24 | 111.1% | -183.1% | ||
| Q1 24 | -36.0% | -169.3% |
资本支出强度RBKBTLSI
| Q4 25 | 6.3% | 0.3% | ||
| Q3 25 | 1.4% | 1.9% | ||
| Q2 25 | 1.4% | 0.8% | ||
| Q1 25 | 0.9% | 8.2% | ||
| Q4 24 | 105.5% | 0.6% | ||
| Q3 24 | 6.3% | 2.3% | ||
| Q2 24 | 1.2% | 0.8% | ||
| Q1 24 | 2.3% | 1.0% |
现金转化率RBKBTLSI
| Q4 25 | 5.03× | — | ||
| Q3 25 | 0.83× | — | ||
| Q2 25 | 0.89× | — | ||
| Q1 25 | 1.89× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 12.27× | — | ||
| Q1 24 | -3.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
